Protocol for evaluating neuronal activity and neurotransmitter release following amyloid-beta oligomer injections into the rat hippocampus
In Alzheimer's disease, there is an imbalance in neurotransmitter release and altered neuronal activation. Here, we present a protocol approach to analyze neuronal activity by combining local field potential (LFP) recording with microdialysis within the same animal. We describe steps for measuring glutamate and GABA levels following hippocampal amyloid-beta oligomer (Aβo) injections in rats. We then detail procedures for assembling the electrode and cannula, surgical implantation and simultaneous in vivo LFP recording, interstitial fluid collection, and Aβo injections.
Authors
- Vincent Hervé (ORCID: https://orcid.org/0000-0002-3495-561X)
- Jonathan Brouillette (ORCID: https://orcid.org/0000-0003-1058-1892)
- Obaï Bin Ka’b Ali (ORCID: https://orcid.org/0000-0003-1830-5569)
- Habib Benali (ORCID: https://orcid.org/0000-0001-7158-1218)
- Laurie Bonenfant
- Mathilde Amyot
- Rime Balafrej
Institutions
- Concordia University (CA)
- Université de Montréal (CA)
Publication Details
- Journal
- STAR Protocols
- Published
- 2025-03-24
- DOI
- https://doi.org/10.1016/j.xpro.2025.103712
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Canada Research Chairs
- Canadian Institutes of Health Research
- Natural Sciences and Engineering Research Council of Canada
- Fonds de Recherche du Québec - Santé